Cargando…
Cholinesterase Inhibitors: Drugs Looking for a Disease?
Maggini and colleagues examine the evidence on cholinesterase inhibitors for treating dementia. "What seemed a biologically plausible intervention," they say, "has not led to a proven, real improvement in patients' well-being."
Autores principales: | Maggini, Marina, Vanacore, Nicola, Raschetti, Roberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434488/ https://www.ncbi.nlm.nih.gov/pubmed/16597173 http://dx.doi.org/10.1371/journal.pmed.0030140 |
Ejemplares similares
-
Cholinesterase Inhibitors in Mild Cognitive Impairment: A Systematic Review of Randomised Trials
por: Raschetti, Roberto, et al.
Publicado: (2007) -
Strengthening the Expanded Programme on Immunization in Africa: Looking beyond 2015
por: Machingaidze, Shingai, et al.
Publicado: (2013) -
Disease Mongering in Drug Promotion: Do Governments Have a Regulatory Role?
por: Mintzes, Barbara
Publicado: (2006) -
The US Food and Drug Administration Provides a Pathway for Licensing Vaccines for Global Diseases
por: Brennan, Michael J.
Publicado: (2009) -
Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage
por: Kesselheim, Aaron S., et al.
Publicado: (2017)